US2010173883A1PendingUtilityA1
7-hydroxyepiandrosterone having neuroprotective activity
Est. expiryJun 29, 2020(expired)· nominal 20-yr term from priority
A61P 9/00A61P 9/10A61P 25/00A61P 25/16A61P 25/02A61P 25/28A61K 31/5685
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
3-Hydroxy-7β-hydroxy steroids and 3-oxo-7β-hydroxy steroids and pharmaceutically acceptable esters thereof are useful for protection against neuronal damage.
Claims
exact text as granted — not AI-modified1 .- 6 . (canceled)
7 . A method of treating neuronal damage in a mammal comprising administering thereto an effective amount of 7α-hydroxyepiandrosterone.
8 . The method according to claim 7 , wherein the neuronal damage is caused by stroke or brain trauma.
9 . The method according to claim 7 , wherein the neuronal damage is caused by Alzheimer's Disease, Parkinson's Disease, Cognitive Impairment No Dementia, spinal cord injury, or peripheral nerve injury.
10 . A method for reducing neuronal cell death following acute neuronal damage in a mammal comprising administering thereto an effective amount of 7α-hydroxyepiandrosterone.
11 . The method according to claim 10 , wherein the acute neuronal damage is caused by stroke.
12 . The method according to claim 10 , wherein the acute neuronal damage is caused by spinal cord injury.
13 . A method for reducing neuronal cell death following chronic neuronal damage in a mammal comprising administering thereto an effective amount of 7α-hydroxyepiandrosterone.
14 . The method according to claim 13 , wherein the chronic neuronal damage is caused by Alzheimer's Disease.
15 . The method according to claim 13 , wherein the chronic neuronal damage is caused by Parkinson's Disease.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.